Insulin does not regulate the promoter of cholesteryl ester transfer protein (CETP) in HIRc/pCETP-CAT cells

Molecular and Cellular Biochemistry

Volumn 211, Issue 1-2, 2000, Pages 1-7

  MacLean, P S ^a   Barakat, H A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

C EBP; CETP promoter; Cholesterol; Insulin

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; INSULIN; INSULIN RECEPTOR;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL LINE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HORMONE ACTION; NONHUMAN; PROMOTER REGION; RAT;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0033802764     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1007027818389     Document Type: Article

References (41)

1. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport
2. Cholesterol ester transfer protein: A molecule with three faces?
3. Increased lipid transfer activities in hyperlipidemic rabbit plasma
4. Plasma lipid transfer protein as a determinant of atherogenicity of monkey plasma lipoproteins
5. Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver
6. Dietary cholesterol increases transcription of the human 3cholesteryl ester transfer protein gene in transgenic mice: Dependence on natural flanking regions
7. Human cholesteryl ester transfer protein gene proximal promoter contains dietary cholesterol positive responsive elements and mediates expression in small intestine and periphery while predominant liver and spleen expression is controlled by 5' distal sequences. Cis-acting sequences mapped in transgenic mice
8. Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice
9. Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: Role in dyslipidemia
10. Unusual high-density lipoprotein subclass distribution during late pregnancy
11. Role of female sex steroids in regulating cholesteryl ester transfer protein in transgenic mice
12. Effects of oral combined hormone replacement therapy on plasm lipids and lipoproteins
13. Effect of acute hyperinsulinemia on cholesteryl ester transfer protein expression in rabbits
14. Regulation of cholesteryl ester transfer activity in adipose tissue: Comparison between hamster and rat species
15. Contribution of glycaemic control, endogenous lipoproteins and cholesteryl ester transfer protein to accelerated cholesteryl ester transfer in IDDM
16. Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus
17. Alterations in reverse cholesterol transport associated with programmable implantable intraperitoneal insulin delivery
18. The effect of acute hyperinsulinemia on plasma cholesteryl ester transfer protein activity in patients with non-insulin-dependent diabetes mellitus and healthy individuals
19. Suppression of plasma cholesteryl ester transfer protein activity in acute hyperinsulinemia and effect of nonesterified fatty acid
20. Insulin inhibits liver expression of the CCAAT/enhancer binding protein β
21. Insulin regulates transcription of the CCAAT/enhancer binding protein (C/EBP) α, β, and δ genes in fully differentiated 3T3-LI adipocytes
22. The CCAAT/enhancer-binding protein trans-activates the human cholesteryl ester transfer protein gene promoter
23. Human liposarcoma cell line, SW 872, secretes cholesteryl ester transfer protein in response to cholesterol
24. Reduced phosphorylation of mitogen-activated protein kinase kinase in response to insulin in cells with truncated C-terminal domain of insulin receptor
25. Insulin stimulates the tyrosine dephosphorylation of pp 125 focal adhesion kinase
26. Insulin activates p21Ras and guanine nucleotide releasing factor in cells expressing wild type and mutant insulin receptors
27. High glucose condition activates protein tyrosine phosphatases and deactivates insulin receptor function in insulin-sensitive rat 1 fibroblasts
28. A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis
29. Isolation, characterization, and assay of lipid transfer proteins
30. Lipoprotein subpopulation distributions in lean, obese, and type 2 diabetic women: A comparison of African and Caucasian Americans
31. Increased plasma cholesteryl ester transfer protein in obese subjects: A possible mechanism for the reduction of serum HDL cholesterol levels in obesity
32. Effect of adiposity on plasma lipid transfer protein activities: A possible link between insulin resistance and high density lipoprotein metabolism
33. Increased plasma cholesteryl ester transfer activity in obese children
34. Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes
35. Isolation of a recombinant copy of the gene encoding C/EBP
36. Is CCAAT/enhancer binding protein a central regulator of energy metabolism
37. CCAAT/enhancer binding protein mRNA is translated into multiple proteins with different transcription activation potentials
38. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family
39. A novel cis-acting element controlling the rat CYP2D5 gene and requiring cooperativity between C/EBPβ and an SP1 factor
40. C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements
41. Determination of tissue specificity of the enhancer by combinatorial operation of tissue-enriched transcription factors: Both HNF-4 and C/EBPβ are required for liver specific activity of the ornithine transcarbamylase enhancer